Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis

This study is a non-interventional observational study. On the baseline (Visit 1), we collect demographic data from all participating subjects according to their daily medical conditions, prescribe drugs and collect validity and safety data according to the research plan in Visit 1 and Visit 2. In addition, we collect data by application on subject's self-awareness symptoms and subject's questionnaire for medical outcome short form health survey (SF-36) every day from the baseline for 4 days.

Inclusion Criteria:Male and female adults 19 years of age or older at the time of screening visitA person who is scheduled to administer the research drug according to the medical judgment of the researcher based on the permissionA person who can understand the information provided to the person and can voluntarily sign a written consent formExclusion Criteria:Those who are contraindicated in administration according to the approval of the research drugPersons participating in other clinical trialsThose who have been judged by Investigator as unsuitable as subjects for this observational study